A Clinical Trial to Evaluate the Effects of a Supplement on Energy and Mood

NCT07398521 | Completed

• 1 other identifier: 20811
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.

Conditions

Mood; Stress

Keywords

Sleep Quality; Magnesium

Outcome Measures

Primary Outcomes (2)

• Change in Energy Levels

  Change in self-reported energy levels following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.

  Baseline, Day 3, Day 7, Day 10, Day 14

• Change in Mood

  Change in self-reported mood following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.

  Baseline, Day 3, Day 7, Day 10, Day 14

Secondary Outcomes (5)

• Change in Stress Levels

  Baseline, Day 3, Day 7, Day 10, Day 14

• Change in Relaxation and Calmness

  Baseline, Day 3, Day 7, Day 10, Day 14

• Change in Balanced Mood

  Baseline, Day 3, Day 7, Day 10, Day 14

• Change in Sleep Quality

  Baseline, Day 3, Day 7, Day 10, Day 14

• Change in Muscle Tension

  Baseline, Day 3, Day 7, Day 10, Day 14

Study Arms (1)

Liposomal Magnesium Complex

EXPERIMENTAL

Participants will consume one packet daily by squeezing the contents directly into the mouth.

Dietary Supplement: Liposomal Magnesium Complex

Interventions

Liposomal Magnesium Complex DIETARY_SUPPLEMENT

The supplement is taken in the morning with the first meal of the day for 14 consecutive days.

Liposomal Magnesium Complex

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Be male or female
• Be aged 18-60
• Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood
• Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
• Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial.
• Anyone willing to refrain from taking any products, prescription medications, or supplements that target energy, mood, stress, and sleep during the test period.
• Anyone willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
• Resides in the United States.

You may not qualify if:

• Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders.
• Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients.
• Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
• Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
• History of diagnosed psychiatric or mood disorders.
• History of diagnosed sleep disorders.
• History of serious illness in the last three months.
• History of substance abuse.
• History of kidney disease.
• History of hormone or endocrine disorders, including but not limited to hypothyroidism, Hashimoto's thyroiditis, polycystic ovarian syndrome (PCOS), and diabetes.
• Planned surgery during the study period.
• Currently partaking in another research study or will be partaking in any other research study for the next 2 weeks, or at any point during this study's duration.
• Anyone unwilling to follow the study protocol.

Sponsors & Collaborators

• Cymbiotika, LLC: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89118, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 4, 2026
• First Posted: February 10, 2026
• Study Start: October 14, 2025
• Primary Completion: December 8, 2025
• Study Completion: December 8, 2025
• Last Updated: February 10, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)